Please login to the form below

Not currently logged in
Email:
Password:

Defitelio

This page shows the latest Defitelio news and features for those working in and with pharma, biotech and healthcare.

Jazz Pharma bags FDA approval for rare disease drug

Jazz Pharma bags FDA approval for rare disease drug

Defitelio given the green light to treat patients who develop severe hepatic VOD. ... Jazz acquired Defitelio as part of its $1bn purchase of Italy's Gentium in 2013.

Latest news

  • SMC: Celgene's Abraxane 'too expensive' for Scotland SMC: Celgene's Abraxane 'too expensive' for Scotland

    But medicines watchdog backs Sovaldi, Invokana, Defitelio, Relvar Ellipta. Pancreatic cancer patients in Scotland should not have NHS access to Celgene's Abraxane, according to guidance from the Scottish Medicines Consortium ... Drugs that received

  • Jazz offers $1bn for Italy's Gentium Jazz offers $1bn for Italy's Gentium

    The drug was approved in Europe in October, despite suggestions - voiced by Gentium itself earlier this year - that concerns about Defitelio's benefit:risk profile might delay registration. ... 10m. Gentium also has a small business unit selling active

  • Gentium expects EMA rejection for defibrotide Gentium expects EMA rejection for defibrotide

    Negative feedback for drug’s use in liver condition associated with stem cell transplantation

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics